Clinical Trials Logo

Clinical Trial Summary

Chronic inflammatory bowel disease (IBD) is associated with an increased risk of colorectal cancer (CRC) in historical cohorts. The pathways of oncogenesis of these CRCs, which are very different clinically from de novo CRCs, are currently unknown. The aim of our work is to identify specific molecular signatures of CRC occurring in the setting of IBD.

Clinical Trial Description


Study Design

Related Conditions & MeSH terms

NCT number NCT05060770
Study type Observational [Patient Registry]
Source Central Hospital, Nancy, France
Status Completed
Start date January 1, 2010
Completion date January 1, 2021

See also
  Status Clinical Trial Phase
Recruiting NCT04157322 - Plasma 5hmC Signatures as a Marker of Colorectal / Appendiceal Peritoneal Metastasis
Completed NCT01557101 - Comparison Colon Capsule Endoscopy vs Optical Colonoscopy for Colorectal Cancer Screening in Familiar-Risk Population Phase 4